FDA Inspection 1160460 — Rizwana Mohseni, DO
The FDA completed an inspection of Rizwana Mohseni, DO on Dec 17, 2021 in Montclair, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 17, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Montclair, CA (United States)
Additional Details
Clinical Investigator (CI)